Techniques: Base pair editing to correct point mutations using a nuclease-dead CRISPR-associated protein 9 (Cas9) variant conjugated to a cytidine deaminase

Drug platforms

TECHNOLOGY: Gene therapy

A CRISPR-based method of editing base pairs could correct point mutations more efficiently than traditional CRISPR-Cas9 gene editing. The

Read the full 221 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE